Cost-benefit analysis of a pharmacist-advocated pneumococcal vaccination program

Formulary

Volumn 36, Issue 2, 2001, Pages 147-156

  Joish, V N ^a   Limcangco, M R M T ^a   Armstrong, E P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

AGED; ARTICLE; BACTERIAL INFECTION; CHILD; COST BENEFIT ANALYSIS; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH SERVICE; HUMAN; IMMUNIZATION; MANAGED CARE ORGANIZATION; PHARMACIST; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; VACCINATION;

EID: 0035101976     PISSN: 1082801X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Immunization policies and vaccine coverage among adults: The risk for missed opportunities
2. Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization practices (ACIP)
3. The burden of pneumococcal disease among adults in developed and developing countries: What is and is not known
4. Streptococcus pneumoniae
5. Health-system pharmacists' role in immunizing adults against pneumococcal disease and influenza
6. A practical guide to establishing vaccine administration services in community pharmacies
7. Pharmacists as vaccine advocates: Roles in community pharmacies, nursing homes, and hospitals
8. A cost-benefit analysis of immunization for pneumococcal pneumonia
9. A benefit-cost analysis of mumps vaccine
10. Cost-effectiveness and cost-benefit analysis of vaccines
11. Cost-benefit analysis of the Polish hepatitis B prevention program
12. Randomized trial of 23-valent pneumococcal capsular polysaccharide vaccine in the prevention of pneumonia in middle-aged and elderly people
13. Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study
14. Clinical trial of pneumococcal vaccine amongst institutional elderly
15. Clinical efficacy of pneumococcal vaccine in the elderly: A randomized, single-blind population based trial
16. The influenza vaccination demonstration project: An expanded policy goal
17. Community pharmacists as immunization advocates. Cost effectiveness of a cue to influenza vaccination